Form 8-K - Current report:
SEC Accession No. 0000950170-23-047001
Filing Date
2023-09-07
Accepted
2023-09-07 16:11:15
Documents
12
Period of Report
2023-09-06
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20230906.htm   iXBRL 8-K 70123
  Complete submission text file 0000950170-23-047001.txt   184480

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcon-20230906_pre.xml EX-101.PRE 9461
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcon-20230906.xsd EX-101.SCH 2481
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcon-20230906_lab.xml EX-101.LAB 12806
6 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20230906_htm.xml XML 4550
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

EIN.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 231242356
SIC: 2836 Biological Products, (No Diagnostic Substances)